Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-062511
Filing Date
2021-11-02
Accepted
2021-11-02 19:06:19
Documents
2
Period of Report
2021-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1542
2 POA DOCUMENT poa.txt EX-24 4708
  Complete submission text file 0001209191-21-062511.txt   7736
Mailing Address C/O PRONAI THERAPEUTICS, INC. 2150 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address
Klencke Barbara (Reporting) CIK: 0001647647 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39866 | Film No.: 211373043

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations